Veradigm Inc. (MDRX)
$10.60 -$0.15 (-1.40%) 3:25 AM 12/11/24
NASDAQ | $USD | Health Information ServicesStock Data
-
Market Cap
$1.18B -
Day's Range
$10.00 - $10.75 -
Volume
- -
52 Week Low / High
$5.01 - $11.80 -
PE Ratio
11.06x -
PEG Ratio
2.42 -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 1
- Strong Buy
- 1
- Buy
- 2
- Hold
- 0
- Sell
- 0
- Strong Sell
- $17.50
- Target Price
Company News
-
Veradigm Inc (MDRX) Announces Strategic Acquisition of ScienceIO to Enhance AI Capabilities — Feb 28th, 2024
Acquisition Announcement: Veradigm Inc (NASDAQ:MDRX) to acquire ScienceIO, a leading healthcare AI platform, for $140 million. Strategic Growth: The acquisition aims to leverage ScienceIO's AI technology on Veradigm's extensive data set to improve healthcare outcomes and lower costs. Finan...
-
Veradigm to Acquire ScienceIO — Feb 27th, 2024
Veradigm to Leverage ScienceIO’s Leading Healthcare Artificial Intelligence (AI) Platform on the Company’s Large-Scale, High-Quality Data Set to Build Advanced, Private Language Models for Healthcare Expected to Provide Highly Differentiated and More Advanced Products to Veradigm Cust...
-
Veradigm to Participate in TD Cowen Annual Health Care Conference — Feb 28th, 2024
CHICAGO, February 28, 2024--(BUSINESS WIRE)--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, today announced that Dr. Yin Ho, Veradigm interim Chief Executive Officer, and Lee Westerfield, interim Chief Financial Officer, will pres...
-
Veradigm Provides Update on its Financial Restatement Process — Feb 27th, 2024
Expects Not to File Required Financial Statements by Nasdaq’s February 27, 2024 Deadline Working Diligently to File Required Financial Statements and Restore Listing Adopts Limited Duration Stockholder Rights Plan CHICAGO, February 27, 2024--(BUSINESS WIRE)--Veradigm Inc. (NASDAQ: MDR...
-
Veradigm Reveals New Insights on the Prevalence of Cardiovascular Conditions in the U.S. — Feb 20th, 2024
Using de-identified data for 53 million unique cardiovascular patients, the report examines prevalence across all 50 states and a variety of demographics CHICAGO, February 20, 2024--(BUSINESS WIRE)--Which region of the U.S. has the highest rates of hypertension, coronary artery disease an...
-
Veradigm to Highlight New EHR-Integrated Care Gap Alert Solution at ViVE 2024 Conference — Feb 22nd, 2024
Recently debuted Veradigm Payer Insights is delivering care cap alerts to thousands of providers and growing fast as demand for payer-provider interoperability continues to increase CHICAGO, February 22, 2024--(BUSINESS WIRE)--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare...
Portfolio
Comprised of 1 portfolios